204 related articles for article (PubMed ID: 30977626)
21. Isolation Methods Influence the Protein Corona Composition on Gold-Coated Iron Oxide Nanoparticles.
Hoang KNL; Wheeler KE; Murphy CJ
Anal Chem; 2022 Mar; 94(11):4737-4746. PubMed ID: 35258278
[TBL] [Abstract][Full Text] [Related]
22. Analysis of temporally evolved nanoparticle-protein corona highlighted the potential ability of gold nanoparticles to stably interact with proteins and influence the major biochemical pathways in Brassica juncea.
Prakash S; Deswal R
Plant Physiol Biochem; 2020 Jan; 146():143-156. PubMed ID: 31751914
[TBL] [Abstract][Full Text] [Related]
23. Exploiting Protein Corona around Gold Nanoparticles Conjugated to p53 Activating Peptides To Increase the Level of Stable p53 Proteins in Cells.
Chan KP; Chao SH; Kah JCY
Bioconjug Chem; 2019 Mar; 30(3):920-930. PubMed ID: 30768246
[TBL] [Abstract][Full Text] [Related]
24. Evolution of the protein corona affects macrophage polarization.
Yang H; Lu S; Wang S; Liu L; Zhu B; Yu S; Yang S; Chang J
Int J Biol Macromol; 2021 Nov; 191():192-200. PubMed ID: 34547310
[TBL] [Abstract][Full Text] [Related]
25. Protein coronas on gold nanorods passivated with amphiphilic ligands affect cytotoxicity and cellular response to penicillin/streptomycin.
Kah JC; Grabinski C; Untener E; Garrett C; Chen J; Zhu D; Hussain SM; Hamad-Schifferli K
ACS Nano; 2014 May; 8(5):4608-20. PubMed ID: 24758495
[TBL] [Abstract][Full Text] [Related]
26. The biomolecular corona of gold nanoparticles in a controlled microfluidic environment.
Digiacomo L; Palchetti S; Giulimondi F; Pozzi D; Zenezini Chiozzi R; Capriotti AL; Laganà A; Caracciolo G
Lab Chip; 2019 Aug; 19(15):2557-2567. PubMed ID: 31243412
[TBL] [Abstract][Full Text] [Related]
27. Effect of a protein corona on the fibrinogen induced cellular oxidative stress of gold nanoparticles.
Kuschnerus I; Lau M; Giri K; Bedford N; Biazik J; Ruan J; Garcia-Bennett A
Nanoscale; 2020 Mar; 12(10):5898-5905. PubMed ID: 32104861
[TBL] [Abstract][Full Text] [Related]
28. In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles.
Hadjidemetriou M; Al-Ahmady Z; Mazza M; Collins RF; Dawson K; Kostarelos K
ACS Nano; 2015 Aug; 9(8):8142-56. PubMed ID: 26135229
[TBL] [Abstract][Full Text] [Related]
29. Probing the modulated formation of gold nanoparticles-beta-lactoglobulin corona complexes and their applications.
Yang J; Wang B; You Y; Chang WJ; Tang K; Wang YC; Zhang W; Ding F; Gunasekaran S
Nanoscale; 2017 Nov; 9(45):17758-17769. PubMed ID: 28869274
[TBL] [Abstract][Full Text] [Related]
30. Simple spectroscopic determination of the hard protein corona composition in AuNPs: albumin at 75.
Vitali M; Casals E; Canals F; Colomé N; Puntes V
Nanoscale; 2020 Aug; 12(29):15832-15844. PubMed ID: 32692793
[TBL] [Abstract][Full Text] [Related]
31. Improving Targeting of Metal-Phenolic Capsules by the Presence of Protein Coronas.
Ju Y; Dai Q; Cui J; Dai Y; Suma T; Richardson JJ; Caruso F
ACS Appl Mater Interfaces; 2016 Sep; 8(35):22914-22. PubMed ID: 27560314
[TBL] [Abstract][Full Text] [Related]
32. Dynamic protein coronas revealed as a modulator of silver nanoparticle sulphidation in vitro.
Miclăuş T; Beer C; Chevallier J; Scavenius C; Bochenkov VE; Enghild JJ; Sutherland DS
Nat Commun; 2016 Jun; 7():11770. PubMed ID: 27278102
[TBL] [Abstract][Full Text] [Related]
33. The importance of selecting a proper biological milieu for protein corona analysis in vitro: Human plasma versus human serum.
Mirshafiee V; Kim R; Mahmoudi M; Kraft ML
Int J Biochem Cell Biol; 2016 Jun; 75():188-95. PubMed ID: 26643610
[TBL] [Abstract][Full Text] [Related]
34. The bio-interface between functionalized Au NR@GO nanoplatforms with protein corona and their impact on delivery and release system.
Assali A; Razzazan S; Akhavan O; Mottaghitalab F; Adeli M; Atyabi F
Colloids Surf B Biointerfaces; 2019 Jan; 173():891-898. PubMed ID: 30551306
[TBL] [Abstract][Full Text] [Related]
35. Effective lock-in strategy for proteomic analysis of corona complexes bound to amino-free ligands of gold nanoparticles.
Zhou M; Tang M; Li S; Peng L; Huang H; Fang Q; Liu Z; Xie P; Li G; Zhou J
Nanoscale; 2018 Jul; 10(26):12413-12423. PubMed ID: 29926046
[TBL] [Abstract][Full Text] [Related]
36. Size Dependence Unveiling the Adsorption Interaction of High-Density Lipoprotein Particles with PEGylated Gold Nanoparticles in Biomolecular Corona Formation.
Jang GJ; Jeong JY; Kang J; Cho W; Han SY
Langmuir; 2021 Aug; 37(32):9755-9763. PubMed ID: 34347501
[TBL] [Abstract][Full Text] [Related]
37. Regulation of Macrophage Recognition through the Interplay of Nanoparticle Surface Functionality and Protein Corona.
Saha K; Rahimi M; Yazdani M; Kim ST; Moyano DF; Hou S; Das R; Mout R; Rezaee F; Mahmoudi M; Rotello VM
ACS Nano; 2016 Apr; 10(4):4421-30. PubMed ID: 27040442
[TBL] [Abstract][Full Text] [Related]
38. Electrical-Charge-Mediated Cancer Cell Targeting via Protein Corona-Decorated Superparamagnetic Nanoparticles in a Simulated Physiological Environment.
Zhao J; Wu S; Qin J; Shi D; Wang Y
ACS Appl Mater Interfaces; 2018 Dec; 10(49):41986-41998. PubMed ID: 30426746
[TBL] [Abstract][Full Text] [Related]
39. Dispersion of Nanoparticles in Different Media Importantly Determines the Composition of Their Protein Corona.
Strojan K; Leonardi A; Bregar VB; Križaj I; Svete J; Pavlin M
PLoS One; 2017; 12(1):e0169552. PubMed ID: 28052135
[TBL] [Abstract][Full Text] [Related]
40. Predicting Cell Association of Surface-Modified Nanoparticles Using Protein Corona Structure - Activity Relationships (PCSAR).
Kamath P; Fernandez A; Giralt F; Rallo R
Curr Top Med Chem; 2015; 15(18):1930-7. PubMed ID: 25961528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
